Zimberelimab (Yu Duo)

Mechanism of action

PD-1 inhibitor

Diseases for which it is used

• Classical Hodgkin lymphoma

History of changes in NMPA indication

• 2021-08-30: Approved for the treatment of recurrent or refractory classical Hodgkin’s lymphoma (cHL).

Also known as

• Code names: AB-122, GLS-010, WBP-3055
• Generic name: sepalizumab
• Brand name: Yu Duo